NIH Re-Approves Four Wisconsin Stem Cell Lines Including WiCell's H9 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The National Institutes of Health has re-approved for ongoing use in federally-funded research the H9 (WA09) human embryonic stem cell line of the WiCell Research Institute, as well as three other original "Wisconsin" lines: H7 (WA07), H13 (WA13), and H14 (WA14).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.